ARS Pharmaceuticals Newsroom

Institutional Owners May Ignore ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$67m Market Cap Decline as Longer-term Profits Stay in the Green

Yahoo FinanceDec 24 23:24

ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies

BenzingaDec 20 06:29

ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies

GlobeNewswireDec 20 06:25

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18 21:00

ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia

BenzingaDec 13 03:35

ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

SECDec 7 05:10 · Announcements

ARS Pharmaceuticals Announces That It Will Be Launching The NeffyinSchools Program In January 2025; The Program Will Provide Eligible Public And Private K-12 Schools In The U.S. The Opportunity To Receive Two Cartons Of Neffy 2mg For Use In Emergency...

BenzingaDec 4 21:19

ARS Pharmaceuticals Announces Planned Launch of NeffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost

GlobeNewswireDec 4 21:00

Trade Alert: Chief Business Officer & Secretary Of ARS Pharmaceuticals Justin Chakma Has Sold Stock

Simply Wall StNov 30 20:05

Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.09 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 15, $ARS Pharmaceuticals(SPRY.US)$ Officer Chakma Justin intends to sell 236.38K shares of its common stock on Nov 15, with a total market value of approximately $4.09

Futu NewsNov 16 04:24

Express News | Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties

BreakingsNov 14 22:00

ARS Pharmaceuticals Insider Sold Shares Worth $10,143,706, According to a Recent SEC Filing

MT NewswiresNov 14 16:18

Express News | ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $26 From $25

BreakingsNov 14 15:58

ARS Pharmaceuticals' Strong Q3 2024 Highlights

TipRanksNov 14 12:15

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$10.14 Million in Common Stock

$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Flynn James E sold 563.27K shares of common stock on Nov 11, 12, 2024 at an average price of $18.01 for a total value of $10.14 million. This

Futu NewsNov 14 09:19

ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 14 01:56 · Conference Call

ARS Pharmaceuticals Shares Are Higher Lower After the Company Reported Better-than-expected Q3 Sales Results.

BenzingaNov 13 21:05

ARS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 13 20:08 · Announcements

ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

SECNov 13 20:03

ARS Pharmaceuticals' Q3 Net Loss Widens

MT NewswiresNov 13 19:58